|
Class 2 Device Recall Nova Biomedical |
 |
Date Initiated by Firm |
March 30, 2004 |
Date Posted |
July 20, 2004 |
Recall Status1 |
Terminated 3 on June 17, 2004 |
Recall Number |
Z-0826-04 |
Recall Event ID |
28725 |
510(K)Number |
K022746
|
Product Classification |
Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph - Product Code CHL
|
Product |
Stat Profile Critical Care Xpress (CCX) Analyzer Catalog Number: 35942 |
Code Information |
Domestic S/N: Y01C03200 Y01C03130 Y01104030 Y01104040 Y01104100 Y01104110 Y01304150 Y01304120 Y01104150 Y01104130 Y01104050 Y01104190 Y01104160 Y01104220 Y01204020 Y01204100 Y01204010 Y01204130 Y01204150 Y01204160 Y01703120 Y01304040 Y01304010 Y01304110 International S/N: Inst. S/N Y01204200 Y01304030 Y01304130 Y01304140 Y01304090 Y01304100 Y01104140 Y01204070 Y01204170 Y01104120 Y01C03150 |
Recalling Firm/ Manufacturer |
Nova Biomedical Corporation 200 Prospect St Waltham MA 02453-3457
|
For Additional Information Contact |
Paul MacDonald 781-647-3700 Ext. 211
|
Manufacturer Reason for Recall |
Incorrectly assembled pumps may result in inconsistent compression of the tubing causing erratic results or calibration problems
|
FDA Determined Cause 2 |
Other |
Action |
Nova Biomedical notified users by telephone on 3/31/04 and conducted follow-up by letter either by email or fax. On-site visit will be scheduled to replace the pump assembly. |
Quantity in Commerce |
35 units |
Distribution |
CA, IL, LA, MA ,NJ, NY, OH, PA, TX
International: Italy ,England, Japan,Turkey., U.A.E., Greece, Thailand, Switzerland, Finland, Saudi Arabia, Italy, Mexico, Trinidad, Ireland, France, Cyprus, Czech Republic, ,Germany |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = CHL and Original Applicant = NOVA BIOMEDICAL CORP.
|
|
|
|